Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar:12:1-18.
doi: 10.1146/annurev-statistics-033121-120121. Epub 2024 Oct 30.

Designs for Vaccine Studies

Affiliations

Designs for Vaccine Studies

M Elizabeth Halloran. Annu Rev Stat Appl. 2025 Mar.

Abstract

Due to dependent happenings, vaccines can have different effects in populations. In addition to direct protective effects in the vaccinated, vaccination in a population can have indirect effects in the unvaccinated individuals. Vaccination can also reduce person-to-person transmission to vaccinated individuals or from vaccinated individuals compared with unvaccinated individuals. Design of vaccine studies has a history extending back over a century. Emerging infectious diseases, such as the SARS-CoV-2 pandemic and the Ebola outbreak in West Africa, have stimulated new interest in vaccine studies. We focus on some recent developments, such as target trial emulation, test-negative design, and regression discontinuity design. Methods for evaluating durability of vaccine effects were developed in the context of both blinded and unblinded placebo crossover studies. The case-ascertained design is used to assess the transmission effects of vaccines. The novel ring vaccination trial design was first used in the Ebola outbreak in West Africa.

Keywords: causal inference; cluster-randomized trial; immune correlates; observational study; regression discontinuity design; ring vaccination; target trial emulation; test-negative design; vaccines.

PubMed Disclaimer

Similar articles

References

    1. Bai H, Lewitus E, Li Y, Thomas PV, Zemil M, et al. 2024. Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding. Nat. Commun 15:3924. - PMC - PubMed
    1. Basta NE, Halloran ME. 2019. Evaluating the effectiveness of vaccines using a regression discontinuity design. Am. J. Epidemiol 188:987–90 - PMC - PubMed
    1. Chakladar S, Rosin S, Hudgens M, Halloran ME, Clemens JD, et al. 2020. Inverse probability weighted estimators of vaccine effects accommodating partial interference and censoring. Biometrics 28:777–88 - PMC - PubMed
    1. Cowling BJ, Lim WW, Perera RAPM, Fang VJ, Leung GM, et al. 2019. Influenza hemagglutination-inhibition antibody titer as a mediator of vaccine-induced protection for influenza B. Clin. Infect. Dis 68:1713–17 - PMC - PubMed
    1. Cox DR. 1958. Planning of Experiments. New York: John Wiley and Sons

LinkOut - more resources